Top Markets
#1 Islamic Coin Islamic Coin +151.51%
#2 Akedo Akedo +69.87%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.42%
#5 Velvet Velvet +46.01%
#6 Cross Cross +36.90%
#7 Black Phoenix Black Phoenix +34.13%
#8 Cap Cap +19.51%
#9 DoubleZero DoubleZero +15.07%
#10 Humanity Humanity +11.75%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Rang in Aktien #39071
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Aktienkurs
$0.0568
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$661.36K
Veränderung (1 Tag)
11.37%
Veränderung (1 Jahr)
-5.33%
Land
US
Handel Hepion Pharmaceuticals, Inc. (HEPA)

Kategorie

Healthcare
Preis HEPA mit Marktkapitalisierung von B
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
HEPA
$0.0568
Marktkapitalisierung von Hepion Pharmaceuticals, Inc.(HEPA)
Marktkapitalisierung: $661.36K
Mit Stand August 2026 hat Hepion Pharmaceuticals, Inc. eine Marktkapitalisierung von $661.36K. Das macht Hepion Pharmaceuticals, Inc. laut unseren Daten zum 39071st wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Hepion Pharmaceuticals, Inc. von 2014 bis 2026
HEPA im Vergleich zu den Top 5 der beliebtesten stocks
Preis für HEPA Vermögenswert B Marktkapitalisierung von B Ergebnisse
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$469,742 $661.36K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +827,009,900.33%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$383,647 $661.36K
Apple Inc. Apple Inc.
AAPL
$4.467T +675,434,042.20%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$358,510 $661.36K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +631,179,244.65%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$317,775 $661.36K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +559,462,337.44%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$245,140 $661.36K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +431,584,807.66%